BMO, Carlyle launch private equity strategy for Canada-February 2024-www.financetom.com

BMO, Carlyle launch private equity strategy for Canada

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BMO, Carlyle launch private equity strategy for Canada

Mar 22, 2024 3:22 AM

March 22 (Reuters) - BMO Global Asset Management said on

Friday it had partnered with U.S. private equity firm Carlyle

Group ( CG ) to broaden access to private markets for Canadian

investors.

Previous page： Allstate Estimates $889 Million Catastrophe Losses in September Next page： Hydrofarm Names New Chief Executive, Finance Chief

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Allstate Estimates $889 Million Catastrophe Losses in September

Oct 17, 2024

08:45 AM EDT, 10/17/2024 (MT Newswires) -- Allstate ( ALL ) said Thursday it estimates catastrophe losses of $889 million for September primarily due to Hurricane Helene. For Q3, total catastrophe losses were $1.7 billion, and $4.55 billion for September year-to-date, Allstate ( ALL ) said. Additionally, Allstate ( ALL ) said its annual reserve review for run-off property-liability performed...

Hydrofarm Names New Chief Executive, Finance Chief

Oct 17, 2024

11:58 AM EDT, 10/17/2024 (MT Newswires) -- Hydrofarm Holdings Group ( HYFM ) said Thursday that Chief Executive and Chairman Bill Toler will retire as CEO and become executive chairman, starting Jan. 1, 2025. Chief Financial Officer John Lindeman will become the new CEO while Chief Accounting Officer Kevin O'Brien will succeed Lindeman as CFO, the company said. The company...

--Zuora to Be Bought by Silver Lake, GIC in $1.70 Billion Deal

Oct 17, 2024

08:45 AM EDT, 10/17/2024 (MT Newswires) -- Price: 9.89, Change: +0.47, Percent Change: +4.99 ...

Kezar to discontinue mid-stage trial for lupus treatment

Oct 17, 2024

Oct 17 (Reuters) - Kezar Life Sciences ( KZR ) said on Thursday it would terminate its mid-stage trial studying its experimental drug in patients with active lupus nephritis and focus on the development of the drug in autoimmune hepatitis. ...